TheAnswerPage

FEBRUARY 25, 2022

Cannabis sativa – One plant, Many crops. Because of the challenges in determining geographical origin of modern plants and the possibility for reproduction across the genus, all plants in the genus are most accurately Cannabis sativa. Block, M.D. Founder, Nurturing Nature® Group Consultants. UF/IFAS Master Gardener (Miami-Dade County).

Sativa 40

Sativa Hybrid Terpenes Indica 40

Cannabis Law Report

MARCH 9, 2019

London law firm Mackrell Turner Garrett, together with a leading food and trading standards barrister, were instructed by the Cannabis Trades Association UK (CTA) to make representations to the European Food Safety Authority (EFSA).

CBD 87

CBD Food Seed-To-Sale Extraction 87

Cannabis Law Report

JANUARY 23, 2020

the European Food Safety Authority and establishes procedures in the. food safety; Having regard to Regulation (EC) no. animal intended for human consumption; Having regard to Regulation (EC) no. 485/2008; Having regard to Regulation (EU) no. food): «Scientific Opinion on the safety of hemp (Cannabis. 1307/2013 of.

Food 45

Food THC Safety Agriculture 45

The Cannigma

JANUARY 13, 2023

Treating migraine pain is one of the instances where inhaled cannabis consumption, such as smoking or vaping , is important for the right effects and speed of delivery. 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines. headaches per month.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. 2018 ; Frankhauser 2008 ). At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45

Safety CBD Clinical Trials Oil 45